Electromed (ELMD) CFO exercises stock options and sells 11,801 shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Electromed, Inc.’s Chief Financial Officer, Bradley M. Nagel, reported a combination of stock option exercises and share sales on June 4, 2026. He exercised options to acquire 9,601 shares of common stock at exercise prices of $10.71 and $10.25 per share, converting derivative awards into common shares.
On the same date, he sold a total of 11,801 common shares in open-market transactions, with weighted average sale prices of approximately $36.34 for 11,620 shares and $37.11 for 181 shares. After these exercises, he retained 2,633 options at an exercise price of $10.71 expiring on June 30, 2033 and 2,166 options at $10.25 expiring on November 10, 2033.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 11,801 shares ($428,936)
Net Sell
6 txns
Insider
Nagel Bradley M.
Role
Chief Financial Officer
Sold
11,801 shs ($429K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) | 4,334 | $0.00 | -- |
| Exercise | Employee Stock Option (right to buy) | 5,267 | $0.00 | -- |
| Exercise | Common Stock | 4,334 | $10.25 | $44K |
| Exercise | Common Stock | 5,267 | $10.71 | $56K |
| Sale | Common Stock | 11,620 | $36.3355 | $422K |
| Sale | Common Stock | 181 | $37.114 | $7K |
Holdings After Transaction:
Employee Stock Option (right to buy) — 2,166 shares (Direct, null);
Common Stock — 26,172 shares (Direct, null)
Footnotes (1)
- Reflects the weighted average price of 11,620 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on June 4, 2026 with sale prices ranging from $36.04 to $37.02 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Reflects the weighted average price of 181 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on June 4, 2026 with sale prices ranging from $37.055 to $37.21 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Scheduled to vest and become exercisable with respect to remaining shares on June 30, 2026.
Key Figures
Shares sold: 11,801 shares
Main sale weighted average price: $36.3355/share
Additional sale weighted average price: $37.114/share
+5 more
8 metrics
Shares sold
11,801 shares
Total common shares sold on June 4, 2026
Main sale weighted average price
$36.3355/share
11,620 common shares sold
Additional sale weighted average price
$37.114/share
181 common shares sold
Options exercised (total shares)
9,601 shares
Common stock acquired via option exercises on June 4, 2026
Option exercise price 1
$10.71/share
5,267 underlying common shares
Option exercise price 2
$10.25/share
4,334 underlying common shares
Remaining options at $10.71
2,633 options
Expire June 30, 2033
Remaining options at $10.25
2,166 options
Expire November 10, 2033
Key Terms
open-market sale, Employee Stock Option (right to buy), derivative security, weighted average price, +1 more
5 terms
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Employee Stock Option (right to buy) financial
"security_title": "Employee Stock Option (right to buy)""
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
weighted average price financial
"Reflects the weighted average price of 11,620 shares of common stock"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
expiration date financial
"expiration_date": "2033-06-30T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What did Electromed (ELMD) CFO Bradley Nagel report in this Form 4?
Electromed CFO Bradley M. Nagel reported exercising stock options for 9,601 common shares and selling 11,801 shares in open-market transactions on June 4, 2026. These moves convert option awards into stock while realizing cash from a portion of his holdings.
What stock options did the Electromed (ELMD) CFO exercise?
The CFO exercised options for 5,267 shares at an exercise price of $10.71 and 4,334 shares at $10.25, totaling 9,601 common shares. These option exercises convert previously granted derivative awards into Electromed common stock at the specified strike prices.
Does the Electromed (ELMD) CFO still hold stock options after these transactions?
Yes. After the June 4, 2026 transactions, the CFO holds 2,633 options with a $10.71 exercise price expiring June 30, 2033, and 2,166 options with a $10.25 exercise price expiring November 10, 2033. These remaining options represent continued potential equity exposure.